Characteristics of patients with atrial fibrillation treated with direct oral anticoagulants and new insights into inappropriate dosing: results from the French National Prospective Registry: PAFF
Article in EP Europace (October 2023)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
A retrospective study of real-world effectiveness and safety of rivaroxaban in patients with non-valvular atrial fibrillation and venous thromboembolism in Saudi Arabia
Article in PeerJ (September 2022)
Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study
Article in Netherlands Heart Journal (January 2021)